Todo esto es muy sencillo de comprobar: cualquiera recuerda la campaña mediática brutal contra la ivermectina, a la que definían de forma despectiva como desparasitante para caballos (que también lo es). Pues buscas artículos anteriores a la pandemia y voilá, resulta que en 2017 era una droga milagrosa con innumerables beneficios para el ser humano según la revista nature: www.nature.com/articles/ja201711
"Over the past decade, the global scientific community have begun to recognize the unmatched value of an extraordinary drug, ivermectin, that originates from a single microbe unearthed from soil in Japan. Work on ivermectin has seen its discoverer, Satoshi Ōmura, of Tokyo’s prestigious Kitasato Institute, receive the 2014 Gairdner Global Health Award and the 2015 Nobel Prize in Physiology or Medicine, which he shared with a collaborating partner in the discovery and development of the drug, William Campbell of Merck & Co. Incorporated. Today, ivermectin is continuing to surprise and excite scientists, offering more and more promise to help improve global public health by treating a diverse range of diseases, with its unexpected potential as an antibacterial, antiviral and anti-cancer agent being particularly extraordinary"
#4 Y en África y Asia la toman millones de personas, por cosas de parásitos que tienen por allí, y no pasa nada. Pero es que también tiene propiedades antivirales y, por lo que he leído recientemente, hasta anticancerígenas.
#5 Todo eso ya lo pone en el extracto que he copiado del artículo de 2017, y aún así fueron con todo porque el dinero que había en juego no creo que sea siquiera cuantificable.
1k 29
Hemos deshabilitado la autenticación con Facebook. Si entras a Mediatize con una cuenta de Facebook, lee esto.
"Over the past decade, the global scientific community have begun to recognize the unmatched value of an extraordinary drug, ivermectin, that originates from a single microbe unearthed from soil in Japan. Work on ivermectin has seen its discoverer, Satoshi Ōmura, of Tokyo’s prestigious Kitasato Institute, receive the 2014 Gairdner Global Health Award and the 2015 Nobel Prize in Physiology or Medicine, which he shared with a collaborating partner in the discovery and development of the drug, William Campbell of Merck & Co. Incorporated. Today, ivermectin is continuing to surprise and excite scientists, offering more and more promise to help improve global public health by treating a diverse range of diseases, with its unexpected potential as an antibacterial, antiviral and anti-cancer agent being particularly extraordinary"